Formosa Laboratories, Inc.(TW:4746)
NT$45.40+0.25 (+0.55%)
TW:4746
Formosa Laboratories, Inc. financials statements
NT$45.40
At close:+0.25 (+0.55%)
Formosa Laboratories, Inc. (4746) Ratios
Formosa Laboratories, Inc. Ratios
TW:4746's free cash flow for Q2 2026 was NT$-344.21M. For the 2026 fiscal year, TW:4746's free cash flow was decreased by NT$-434.24M and operating cash flow was NT$90.03M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.91 | 2.49 | 1.62 | 1.32 | 1.52 |
| Quick Ratio | 1.32 | 1.76 | 1.12 | 0.81 | 0.83 |
| Cash Ratio | 0.39 | 0.58 | 0.47 | 0.41 | 0.31 |
| Solvency Ratio | 0.19 | 0.13 | 0.11 | 0.14 | 0.39 |
| Operating Cash Flow Ratio | 0.45 | 0.31 | 0.26 | 0.20 | 0.13 |
| Short-Term Operating Cash Flow Coverage | 0.85 | 0.65 | 0.42 | 0.30 | 0.21 |
| Net Current Asset Value | NT$ 385.93M | NT$ 619.41M | NT$ -182.32M | NT$ -803.38M | NT$ -795.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.28 | 0.30 | 0.30 | 0.28 |
| Debt-to-Equity Ratio | 0.47 | 0.51 | 0.54 | 0.51 | 0.46 |
| Debt-to-Capital Ratio | 0.32 | 0.34 | 0.35 | 0.34 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.20 | 0.26 | 0.21 | 0.18 | 0.21 |
| Financial Leverage Ratio | 1.78 | 1.81 | 1.80 | 1.70 | 1.62 |
| Debt Service Coverage Ratio | 0.79 | 0.53 | 0.48 | 0.33 | 1.04 |
| Interest Coverage Ratio | 24.25 | 18.93 | 19.43 | 19.71 | 39.28 |
| Debt to Market Cap | 0.55 | 0.46 | 0.33 | 0.42 | 0.49 |
| Interest Debt Per Share | 33.76 | 32.76 | 34.09 | 31.77 | 30.17 |
| Net Debt to EBITDA | 1.83 | 3.40 | 2.18 | 3.06 | 1.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.89% | 43.30% | 44.11% | 36.92% | 30.91% |
| EBIT Margin | 16.56% | 5.03% | 3.93% | 9.36% | 35.50% |
| EBITDA Margin | 27.87% | 15.79% | 26.68% | 21.87% | 50.62% |
| Operating Profit Margin | 16.56% | 15.85% | 15.48% | 10.11% | 35.06% |
| Pretax Profit Margin | 10.34% | 4.19% | 3.27% | 8.85% | 34.61% |
| Net Profit Margin | 9.09% | 3.32% | 2.90% | 5.76% | 39.75% |
| Continuous Operations Profit Margin | 8.16% | 1.35% | -1.20% | 5.56% | 32.92% |
| Net Income Per EBT | 87.91% | 79.37% | 88.66% | 65.07% | 114.86% |
| EBT Per EBIT | 62.47% | 26.42% | 21.10% | 87.48% | 98.71% |
| Return on Assets (ROA) | 3.19% | 1.13% | 0.93% | 1.70% | 10.39% |
| Return on Equity (ROE) | 5.69% | 2.05% | 1.67% | 2.88% | 16.89% |
| Return on Capital Employed (ROCE) | 7.35% | 6.50% | 6.49% | 3.96% | 11.44% |
| Return on Invested Capital (ROIC) | 5.07% | 1.91% | -2.00% | 2.11% | 9.51% |
| Return on Tangible Assets | 3.27% | 1.15% | 0.94% | 1.73% | 10.61% |
| Earnings Yield | 6.89% | 1.90% | 1.03% | 2.45% | 18.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.17 | 3.77 | 4.26 | 4.55 | 4.06 |
| Payables Turnover | 10.28 | 12.30 | 12.06 | 12.74 | 10.73 |
| Inventory Turnover | 1.64 | 1.57 | 1.53 | 1.48 | 1.32 |
| Fixed Asset Turnover | 0.78 | 0.76 | 0.72 | 0.64 | 0.53 |
| Asset Turnover | 0.35 | 0.34 | 0.32 | 0.30 | 0.26 |
| Working Capital Turnover Ratio | 1.57 | 1.72 | 2.90 | 3.36 | 4.68 |
| Cash Conversion Cycle | 274.18 | 300.09 | 294.64 | 297.64 | 331.44 |
| Days of Sales Outstanding | 87.57 | 96.86 | 85.66 | 80.18 | 89.88 |
| Days of Inventory Outstanding | 222.13 | 232.90 | 239.25 | 246.12 | 275.60 |
| Days of Payables Outstanding | 35.52 | 29.67 | 30.27 | 28.65 | 34.03 |
| Operating Cycle | 309.70 | 329.76 | 324.91 | 326.29 | 365.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 12.19 | 6.04 | 6.88 | 5.35 | 2.72 |
| Free Cash Flow Per Share | 4.38 | 1.15 | 2.38 | 1.69 | -1.77 |
| Dividend Paid and CapEx Coverage Ratio | 1.09 | 0.88 | 1.25 | 0.95 | 0.61 |
| Capital Expenditure Coverage Ratio | 1.56 | 1.24 | 1.53 | 1.46 | 0.61 |
| Operating Cash Flow Coverage Ratio | 0.36 | 0.19 | 0.20 | 0.17 | 0.09 |
| Operating Cash Flow to Sales Ratio | 0.27 | 0.15 | 0.19 | 0.17 | 0.10 |
| Free Cash Flow Yield | 7.38% | 1.67% | 2.33% | 2.30% | -2.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.16 | 52.52 | 97.14 | 40.83 | 5.54 |
| Price-to-Sales (P/S) Ratio | 1.32 | 1.75 | 2.81 | 2.35 | 2.20 |
| Price-to-Book (P/B) Ratio | 0.82 | 1.08 | 1.62 | 1.18 | 0.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.55 | 59.76 | 42.87 | 43.52 | -34.14 |
| Price-to-Operating Cash Flow Ratio | 4.87 | 11.39 | 14.84 | 13.74 | 22.23 |
| Price-to-Earnings Growth (PEG) Ratio | 0.09 | 2.12 | -2.33 | -0.49 | 0.03 |
| Enterprise Value Multiple | 6.56 | 14.47 | 12.72 | 13.80 | 6.04 |
| Enterprise Value | 8.87B | 10.81B | 14.80B | 11.36B | 9.61B |
| EV to EBITDA | 6.56 | 14.47 | 12.72 | 13.80 | 6.04 |
| EV to Sales | 1.83 | 2.28 | 3.39 | 3.02 | 3.06 |
| EV to Free Cash Flow | 18.78 | 78.07 | 51.74 | 55.93 | -47.42 |
| EV to Operating Cash Flow | 6.74 | 14.88 | 17.91 | 17.67 | 30.89 |
| Tangible Book Value Per Share | 77.07 | 70.11 | 66.59 | 62.98 | 64.31 |
| Shareholders’ Equity Per Share | 71.89 | 63.90 | 62.97 | 62.54 | 64.67 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.68 | 1.37 | 0.35 | 0.04 |
| Revenue Per Share | 44.96 | 39.34 | 36.27 | 31.31 | 27.48 |
| Net Income Per Share | 4.09 | 1.31 | 1.05 | 1.80 | 10.92 |
| Tax Burden | 0.88 | 0.79 | 0.89 | 0.65 | 1.15 |
| Interest Burden | 0.62 | 0.83 | 0.83 | 0.95 | 0.97 |
| Research & Development to Revenue | 0.15 | 0.17 | 0.19 | 0.21 | 0.22 |
| SG&A to Revenue | 0.11 | 0.11 | 0.10 | 0.11 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.62 | 3.67 | 6.55 | 1.93 | 0.29 |
Currency in TWD
